{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:58:58Z","timestamp":1781765938131,"version":"3.54.5"},"reference-count":27,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Human allogeneic umbilical cord blood serum stands out as a potent adjunct to conventional therapies for ocular surface disorders related to severe Dry Eye Disease. By expediting ocular surface regeneration and fostering epithelial integrity, umbilical cord blood serum not only enhances subjective patient experiences but also improves objective clinical indicators. This makes it particularly useful in patients with corneal ulcers through ocular surface regeneration and anti-inflammatory activity. This retrospective, interventional, non-randomized clinical study aims to explore the efficacy of allogenic umbilical cord blood serum in patients who had previously received other treatments unsuccessfully. This study was a retrospective, non-comparative, interventional clinical study involving 55 patients (35 females and 20 males) aged 18\u201382 years with severe Dry Eye Disease who were unresponsive to standard treatments. The study was conducted at Eye Center \u201cG.B. Morgagni-DSV\u201d, Catania, Italy. Patients were categorized based on the etiology of severe Dry Eye Disease into four groups: group I consisted of 26 patients with filamentary keratitis and corneal ulcers associated with rheumatologic diseases such as Sjogren\u2019s syndrome and systemic sclerosis; group II comprised 15 patients with graft-versus-host disease; group III consisted of 10 patients with corneal neurotrophic ulcers; group IV included four patients with Steven\u2013Johnson syndrome. Outcomes evaluated before and after treatment were OSDI (Ocular Surface Disease Index) and SANDE (Symptom Assessment in Dry Eye) Questionnaires, VAS (Visual Analog Scale), Slit-Lamp Examination, Esthesiometry, Lissamine Green Staining, NIBUT (Non-Invasive Break-Up Time) and BUT, Fluorescein Staining with Photography and Oxford Classification, Schirmer Test, Best-Corrected Visual Acuity (BCVA), Meibography. We observed a significant improvement in SANDE, VAS and OSDI questionnaires, Schirmer Test, BUT, BCVA, and Oxford classification after treatment with allogeneic cord blood serum eyedrops. Clinical variables, such as corneal inflammation, conjunctivalization, corneal neovascularization, or pain, were also considered individually. Nevertheless, pain and inflammation reduced markedly over time until completely healed in all cases. Our study highlights the remarkable efficacy of allogeneic cord blood serum eyedrops in patients with severe Dry Eye Disease who have shown absent or inadequate response to usual treatments for dry eye. This underscores the need for further comprehensive investigations in this field.<\/jats:p>","DOI":"10.3390\/ijms262110782","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:02:03Z","timestamp":1762419723000},"page":"10782","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Allogeneic Umbilical Cord Blood Serum Eyedrops for the Treatment of Severe Dry Eye Disease Patients"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0999-5545","authenticated-orcid":false,"given":"Marco","family":"Zeppieri","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy"},{"name":"Department of Medicine, Surgery and Health Sciences, University of Trieste, 34127 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0059-5253","authenticated-orcid":false,"given":"Giuseppe","family":"Gagliano","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2969-8610","authenticated-orcid":false,"given":"Matteo","family":"Capobianco","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8424-0068","authenticated-orcid":false,"given":"Caterina","family":"Gagliano","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Enna \u201cKore\u201d, Piazza dell\u2019Universit\u00e0, 94100 Enna, Italy"},{"name":"Eye Center \u201cG.B. Morgagni-DSV\u201d, 95125 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6807-9455","authenticated-orcid":false,"given":"Francesco","family":"Cappellani","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Enna \u201cKore\u201d, Piazza dell\u2019Universit\u00e0, 94100 Enna, Italy"},{"name":"Eye Center \u201cG.B. Morgagni-DSV\u201d, 95125 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppa","family":"Tancredi","sequence":"additional","affiliation":[{"name":"Sciacca Cord Blood Bank, 92019 Sciacca, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1051-876X","authenticated-orcid":false,"given":"Alessandro","family":"Avitabile","sequence":"additional","affiliation":[{"name":"Neurovisual Science Technology (NEST) srl, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7556-6952","authenticated-orcid":false,"given":"Ludovica","family":"Cannizzaro","sequence":"additional","affiliation":[{"name":"Neurovisual Science Technology (NEST) srl, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7938-876X","authenticated-orcid":false,"given":"Fabiana","family":"D\u2019Esposito","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Enna \u201cKore\u201d, Piazza dell\u2019Universit\u00e0, 94100 Enna, Italy"},{"name":"Imperial College Ophthalmic Research Group (ICORG) Unit, Imperial College, London NW1 5QH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e12572","DOI":"10.1097\/MD.0000000000012572","article-title":"Sex hormone therapy\u2019s effect on dry eye syndrome in postmenopausal women: A meta-analysis of randomized controlled trials","volume":"97","author":"Liu","year":"2018","journal-title":"Medicine"},{"key":"ref_6","first-page":"107","article-title":"Dry Eye Disease. A Review","volume":"77","year":"2021","journal-title":"Czech Slovak Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10792-014-9969-x","article-title":"The role and treatment of inflammation in dry eye disease","volume":"34","author":"Yagci","year":"2014","journal-title":"Int. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.det.2019.05.014","article-title":"Review of Graft-Versus-Host Disease","volume":"37","author":"Ramachandran","year":"2019","journal-title":"Dermatol. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.0958-7578.2005.00559.x","article-title":"Epitheliotrophic capacity of plasma vs serum in vitro","volume":"15","author":"Hartwig","year":"2005","journal-title":"Transfus. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.transci.2017.07.023","article-title":"Blood-derived eye drops for cornea\/ocular surface diseases","volume":"56","author":"Giannaccare","year":"2017","journal-title":"Transfus. Apher. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.transci.2015.11.011","article-title":"Sustained benefits of autologous serum eye drops on self-reported ocular symptoms and vision-related quality of life in Australian patients with dry eye and corneal epithelial defects","volume":"53","author":"Mondy","year":"2015","journal-title":"Transfus Apher Sci."},{"key":"ref_12","first-page":"145","article-title":"Maternal peripheral vs cord blood for eye drops","volume":"14","author":"Versura","year":"2016","journal-title":"Blood Transfus."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10517-019-04670-2","article-title":"Cord blood serum\/plasma: Cytokine profile","volume":"168","author":"Romanov","year":"2019","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.ico.0000183484.85636.b6","article-title":"Umbilical cord serum eyedrops for dry eye","volume":"25","author":"Yoon","year":"2006","journal-title":"Cornea"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bmt.1705566","article-title":"UCBS in GVHD dry eye","volume":"39","author":"Yoon","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2007.03.016","article-title":"Autologous vs umbilical cord serum eye drops","volume":"144","author":"Yoon","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"ref_17","first-page":"e396","article-title":"Autologous vs allogeneic vs. UC sera in severe DED: DB-RCT","volume":"100","author":"Verdugo","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/bjophthalmol-2019-314859","article-title":"Allogeneic sources for severe dry eye: Multicentre randomized crossover","volume":"104","author":"Campos","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/ICO.0b013e3182580762","article-title":"Quality-controlled cord blood serum in severe epithelial damage (dry eye)","volume":"32","author":"Versura","year":"2013","journal-title":"Cornea"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3855\/jidc.4733","article-title":"Protocol for microbiologically safe autologous serum eye-drops","volume":"9","author":"Blasetti","year":"2015","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00417-019-04301-6","article-title":"Ocular surface alterations in ocular GVHD","volume":"257","author":"Giannaccare","year":"2019","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000354380","article-title":"Neurotrophic keratitis","volume":"231","author":"Semeraro","year":"2014","journal-title":"Ophthalmologica"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1096\/fj.12-225185","article-title":"VEGF promotes recovery of injured corneal nerves","volume":"27","author":"Pan","year":"2013","journal-title":"FASEB J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.51329\/mehdiophthal1463","article-title":"UC blood platelet lysate for resistant corneal ulcer","volume":"11","author":"Dawood","year":"2023","journal-title":"Med. Hypothesis Discov. Innov. Ophthalmol. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/djo.djo_17_23","article-title":"Evaluation of the effect of umbilical cord blood serum therapy in resistant infected corneal ulcers","volume":"24","author":"Elsawy","year":"2023","journal-title":"Delta J. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.1111\/aos.12710","article-title":"Autologous serum and plasma rich in growth factors in ophthalmology: Preclinical and clinical studies","volume":"93","author":"Anitua","year":"2015","journal-title":"Acta Ophthalmol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10782\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:03:53Z","timestamp":1762419833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":27,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262110782"],"URL":"https:\/\/doi.org\/10.3390\/ijms262110782","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}